查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1928862

月經疼痛緩解產品市場機會、成長要素、產業趨勢分析及2026年至2035年預測

Menstrual Pain Products Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035
出版日期: | 出版商: Global Market Insights Inc. | 英文 210 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球月經疼痛產品市場預計到 2025 年將達到 84 億美元，到 2035 年將達到 136 億美元，年複合成長率為 5.1%。

經痛產品市場-IMG1

這一成長主要源於全球範圍內越來越多的女性報告月經不適，以及圍繞月經健康的廣泛討論、減少污名化和提高健康素養。女性在應對月經越來越有信心，也更願意選擇符合自身舒適度、安全性和長期健康目標的解決方案。對藥物止痛長期副作用的擔憂也促使消費者關注強調天然、非侵入性和個人化照護的替代方法。同時，永續性因素也在影響購買決策，環保和有機產品也越來越受到消費者的青睞。這些行為、醫療和環境因素的綜合作用持續重塑市場需求模式，並支持已開發經濟體和新興經濟體市場的持續成長。

市場覆蓋範圍
開始年份 2025
預測年份 2026-2035
起始值 84億美元
預測金額 136億美元
複合年成長率 5.1%

傳統店面銷售藥市場預計到 2025 年將創造 28 億美元的收入，從 2026 年到 2035 年將以 5.5% 的複合年成長率成長。這些產品之所以繼續被廣泛使用，是因為消費者對其高度信任、能夠快速緩解疼痛、在零售店廣泛銷售，以及藥局和量販店通路中擁有值得信賴的品牌的悠久歷史。

預計到2025年，線上銷售將佔總銷售額的67.1%。數位平台透過提供便利性、豐富的選擇、極具競爭力的價格以及訂閱配送選項，徹底改變了消費者獲取產品的方式。直銷模式和個人化購物體驗的興起，進一步鞏固了線上分銷的主導地位。

美國月經疼痛緩解產品市場預計到 2025 年將達到 15 億美元，從 2026 年到 2035 年將以 6.2% 的複合年成長率成長。人們對月經健康狀況的高度關注、強大的購買力以及先進的醫療保健基礎設施，持續推動創新非藥物疼痛管理解決方案的普及。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章業界考察

  • 生態系分析
    • 供應商情況
    • 利潤率
    • 每個階段的附加價值
    • 影響價值鏈的因素
  • 產業影響因素
    • 促進要素
      • 月經發生率不斷上升，以及人們健康意識的增強
      • 轉向非藥物和天然解決方案
      • 有機和環保經期用品越來越受歡迎
    • 產業潛在風險與挑戰
      • 發展中國家與月經及相關產品有關的社會議題
      • 月經用品對環境的負面影響
    • 機會
      • 天然、草本、環保產品
      • 個人化與數位健康整合
  • 成長潛力分析
  • 未來市場趨勢
  • 科技與創新趨勢
    • 當前技術趨勢
    • 新興技術
  • 價格趨勢
    • 按地區
    • 依產品類型
  • 監管環境
    • 標準和合規要求
    • 區域法規結構
    • 認證標準
  • 貿易統計
    • 主要進口國
    • 主要出口國
  • 波特分析
  • PESTEL 分析
  • 消費行為分析
    • 購買模式
    • 偏好分析
    • 消費行為的區域差異
    • 電子商務對購買決策的影響

第4章 競爭情勢

  • 介紹
  • 公司市佔率分析
    • 按地區
      • 北美洲
      • 歐洲
      • 亞太地區
      • 拉丁美洲
      • 中東和非洲
  • 企業矩陣分析
  • 主要市場公司的競爭分析
  • 競爭定位矩陣
  • 重大進展
    • 併購
    • 夥伴關係與合作
    • 新產品發布
    • 擴張計劃

第5章 依產品類型分類的市場估算與預測，2022-2035年

  • 非處方藥
    • 非類固醇消炎劑（NSAIDs）
    • 止痛藥
    • 抗驚厥藥
  • 局部止痛藥
    • 含薄荷醇的乳霜和凝膠
    • Lidocaine乳膏
    • 辣椒素貼片
    • CBD潤唇膏和滾珠
  • 熱療產品
    • 免洗熱敷貼
    • 微波爐適用加熱包
    • 電暖墊
    • 穿戴式保暖腰帶
  • 穿戴式止痛裝置
    • 經皮神經電刺激（TENS）設備
    • 智慧腰帶，具備加熱和振動功能
    • 應用程式連接裝置
  • 草藥和天然療法
    • 花草茶
    • 精油滾珠型
    • 補充
  • 混合和多模態解決方案

第6章 按應用領域分類的市場估算與預測，2022-2035年

  • 預防性使用
  • 緩解急性疼痛
  • 慢性疼痛管理
  • 隨時隨地的舒適

第7章 2022-2035年按價格分類的市場估計與預測

  • 低價位
  • 中號
  • 高價位範圍

第8章 按年齡層別分類的市場估計與預測，2022-2035年

  • 成年雌性
  • 少女

9. 2022-2035年按分銷管道分類的市場估算與預測

  • 線上
    • 電子商務
    • 我們的網站
  • 離線
    • 大型零售商店
    • 健康與保健專賣店
    • 訂閱服務
    • 藥房和藥品商店
    • 其他

第10章 2022-2035年各地區市場估計與預測

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 馬來西亞
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第11章 公司簡介

  • Angelini Pharma
  • Beurer
  • Bridges CHC
  • Chiaro Technology
  • Cora
  • Livia by iPulse Medical
  • Matri
  • Meyer Organics
  • Nua
  • Ovira
  • Sirona Hygiene
  • SteadySense
  • Sumitomo Pharma America
  • ThermaCare
  • Thermaissance
  • Welme
簡介目錄
Product Code: 15461

The Global Menstrual Pain Products Market was valued at USD 8.4 billion in 2025 and is estimated to grow at a CAGR of 5.1% to reach USD 13.6 billion by 2035.

Menstrual Pain Products Market - IMG1

Growth is strongly supported by a higher number of women reporting menstrual discomfort worldwide and by broader conversations around menstrual well-being that have reduced stigma and improved health literacy. Women are increasingly confident in managing their menstrual needs and are actively choosing solutions that align with comfort, safety, and long-term wellness goals. Concerns related to the long-term effects of drug-based pain relief have also shifted consumer interest toward alternative approaches that emphasize natural, non-invasive, and personalized care. At the same time, sustainability considerations are influencing purchasing decisions, as environmentally responsible and organic options gain greater acceptance. Together, these behavioral, medical, and environmental factors continue to reshape demand patterns and support consistent market growth across both developed and emerging economies.

Market Scope
Start Year2025
Forecast Year2026-2035
Start Value$8.4 Billion
Forecast Value$13.6 Billion
CAGR5.1%

The traditional over-the-counter solutions segment generated USD 2.8 billion in 2025 and is forecast to grow at a CAGR of 5.5% from 2026 to 2035. These products continue to be widely used due to strong consumer confidence, rapid pain relief, broad retail availability, and the long-standing presence of trusted brands across pharmacy and mass-market channels.

The online sales segment accounted for 67.1% share in 2025. Digital platforms have transformed product access by offering convenience, broader assortments, competitive pricing, and recurring delivery options. The growth of direct-to-consumer models and personalized purchasing experiences has further strengthened the dominance of online distribution.

U.S. Menstrual Pain Products Market reached USD 1.5 billion in 2025 and is projected to grow at a CAGR of 6.2% from 2026 to 2035. High awareness of menstrual health conditions, strong purchasing power, and advanced healthcare infrastructure continue to encourage the adoption of innovative and non-drug pain management solutions.

Key companies active in the Global Menstrual Pain Products Market include Ovira, Angelini Pharma, ThermaCare, Nua, Chiaro Technology, Sumitomo Pharma America, Sirona Hygiene, Beurer, Welme, SteadySense, Cora, Matri, Livia by iPulse Medical, Meyer Organics, Thermaissance, and Bridges CHC. Companies operating in the Global Menstrual Pain Products Market are focusing on innovation, brand differentiation, and consumer engagement to strengthen their market position. Many players are investing in product development to deliver discreet, wearable, and technology-enabled solutions that improve comfort and usability. Strategic partnerships, especially with digital platforms and wellness communities, help brands expand visibility and reach targeted audiences. Firms are also emphasizing sustainability through responsible sourcing, eco-conscious packaging, and transparent manufacturing practices.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope and definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/Country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional
    • 2.2.2 Product type
    • 2.2.3 Usage
    • 2.2.4 Price
    • 2.2.5 Age group
    • 2.2.6 Distribution channel
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Supplier landscape
    • 3.1.2 Profit margin
    • 3.1.3 Value addition at each stage
    • 3.1.4 Factor affecting the value chain
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising dysmenorrhea prevalence & health awareness
      • 3.2.1.2 Shift toward non-pharmaceutical & natural solutions
      • 3.2.1.3 Increasing inclination towards adoption of organic and eco-friendly menstrual products
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Social challenges associated with menstruation and its products in developing countries
      • 3.2.2.2 Adverse effects of menstrual products on the environment
    • 3.2.3 Opportunities
      • 3.2.3.1 Natural, herbal & eco-friendly products
      • 3.2.3.2 Personalized & digital health integration
  • 3.3 Growth potential analysis
  • 3.4 Future market trends
  • 3.5 Technology and innovation landscape
    • 3.5.1 Current technological trends
    • 3.5.2 Emerging technologies
  • 3.6 Price trends
    • 3.6.1 By region
    • 3.6.2 By product type
  • 3.7 Regulatory landscape
    • 3.7.1 Standards and compliance requirements
    • 3.7.2 Regional regulatory frameworks
    • 3.7.3 Certification standards
  • 3.8 Trade statistics
    • 3.8.1 Major importing countries
    • 3.8.2 Major exporting countries
  • 3.9 Porter';s analysis
  • 3.10 PESTEL analysis
  • 3.11 Consumer behavior analysis
    • 3.11.1 Purchasing patterns
    • 3.11.2 Preference analysis
    • 3.11.3 Regional variations in consumer behavior
    • 3.11.4 Impact of e-commerce on buying decisions

Chapter 4 Competitive Landscape, 2025

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 By Region
      • 4.2.1.1 North America
      • 4.2.1.2 Europe
      • 4.2.1.3 Asia Pacific
      • 4.2.1.4 Latin America
      • 4.2.1.5 Middle East & Africa
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key developments
    • 4.6.1 Mergers & acquisitions
    • 4.6.2 Partnerships & collaborations
    • 4.6.3 New product launches
    • 4.6.4 Expansion plans

Chapter 5 Market Estimates & Forecast, By Product Type, 2022 - 2035, (USD Billion) (Million Units)

  • 5.1 Key trends
  • 5.2 OTC pharmaceuticals
    • 5.2.1 NSAIDs
    • 5.2.2 Analgesics
    • 5.2.3 Antispasmodics
  • 5.3 Topical pain relief
    • 5.3.1 Menthol-based creams and gels
    • 5.3.2 Lidocaine creams
    • 5.3.3 Capsaicin patches
    • 5.3.4 CBD-infused balms and roll-ons
  • 5.4 Heat therapy products
    • 5.4.1 Disposable heat patches
    • 5.4.2 Microwaveable heat packs
    • 5.4.3 Electric heating pads
    • 5.4.4 Wearable heat belts
  • 5.5 Wearable pain relief devices
    • 5.5.1 TENS units
    • 5.5.2 Smart belts with heat/vibration
    • 5.5.3 App-connected devices
  • 5.6 Herbal & natural remedies
    • 5.6.1 Herbal teas
    • 5.6.2 Essential oil roll-ons
    • 5.6.3 Supplements
  • 5.7 Combination & multi-modal solutions

Chapter 6 Market Estimates & Forecast, By Usage, 2022 - 2035, (USD Billion) (Million Units)

  • 6.1 Key trends
  • 6.2 Preventive use
  • 6.3 Acute pain relief
  • 6.4 Chronic pain management
  • 6.5 On-the-go relief

Chapter 7 Market Estimates & Forecast, By Price, 2022 - 2035, (USD Billion) (Million Units)

  • 7.1 Key trends
  • 7.2 Low
  • 7.3 Medium
  • 7.4 High

Chapter 8 Market Estimates & Forecast, By Age Group, 2022 - 2035, (USD Billion) (Million Units)

  • 8.1 Key trends
  • 8.2 Adult women
  • 8.3 Teen girls

Chapter 9 Market Estimates & Forecast, By Distribution Channel, 2022 - 2035, (USD Billion) (Million Units)

  • 9.1 Key trends
  • 9.2 Online
    • 9.2.1 E-commerce
    • 9.2.2 Company website
  • 9.3 Offline
    • 9.3.1 Mega retail stores
    • 9.3.2 Health & wellness stores
    • 9.3.3 Subscription services
    • 9.3.4 Pharmacies and drugstores
    • 9.3.5 Others

Chapter 10 Market Estimates & Forecast, By Region, 2022 - 2035, (USD Billion) (Million Units)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Italy
    • 10.3.5 Spain
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 India
    • 10.4.3 Japan
    • 10.4.4 South Korea
    • 10.4.5 Australia
    • 10.4.6 Indonesia
    • 10.4.7 Malaysia
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Argentina
  • 10.6 MEA
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 South Africa

Chapter 11 Company Profiles

  • 11.1 Angelini Pharma
  • 11.2 Beurer
  • 11.3 Bridges CHC
  • 11.4 Chiaro Technology
  • 11.5 Cora
  • 11.6 Livia by iPulse Medical
  • 11.7 Matri
  • 11.8 Meyer Organics
  • 11.9 Nua
  • 11.10 Ovira
  • 11.11 Sirona Hygiene
  • 11.12 SteadySense
  • 11.13 Sumitomo Pharma America
  • 11.14 ThermaCare
  • 11.15 Thermaissance
  • 11.16 Welme